促果斷取消限聚令 何(柏)良:無科學證據支持且高成本低效益
港大感染及傳染病中心總監何(柏)良在電台節目表示,限聚令並沒有科學證據支持,因疫情初期本港未有疫苗下,故限聚令才有需要推行,但觀乎現時疫苗接種情況,限聚令就變得高成本、低效益,影響市民,尤其基層市民及長者的社交生活,認為是不可持續,應果斷取消。
他續指,世界各地有很多變種病毒,現階段難以預測,最後哪些病毒會橫掃全球,最重要是守著兩條線,即疫苗接種,特別是60歲以上人士,另外是高風險人士要及早診斷,如確診要在黃金時間內服食新冠口服藥。
他指,不論採取任何邊境措施,均有機會讓病毒流入社區,頻密檢測只能拖慢病毒進入本港的時間,汲取年初教訓,應對方法就是「谷針」;他補充,與國際比較,香港兒童疫苗接種的成績已很好,認為不應給予家長太大壓力,宜多聽他們的擔心,藉鼓勵及解釋,釋除疑慮。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.